Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE)

NCT ID: NCT06380218

Last Updated: 2024-04-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-11

Study Completion Date

2025-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective is to evaluate the effect of a nutritional prevention program associated with the consumption of "Primevère margarine" on the quality of life of women at risk of cardiovascular disease after 10 group coaching sessions in nutrition and physical activity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective is to evaluate the effect of a nutritional prevention program associated with the consumption of "Primevère margarine" on the quality of life of women aged 40 to 65 with cardiovascular risk 3 months after 10 group coaching sessions.

The nutritional prevention program includes tools and 10 collective workshops to change the life behaviours (eating habits and physical activity) by assessing :

* Food balance and diversity
* Eating behaviour and representations
* Level of knowledge in nutrition
* Level of physical activity and physical inactivity
* Physical abilities: strength, balance, flexibility, cardio respiratory endurance, recovery capacity
* Behavioural barriers and educational levers to improve women's cardiovascular health

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nutrional and physical activity program

10 collective combined workshops of nutrition and physical activity = 1 per week during 10 weeks associated to margarine consumption

Group Type EXPERIMENTAL

Nutrional and physical activity program

Intervention Type BEHAVIORAL

Nutritional prevention and physical activity workshops associated with a substitution of saturated and/or trans fatty acids by cis-unsaturated acids via the consumption of Primevère margarine to influence lifestyle habits, quality of life and improvement of the lipid profile of women with cardiovascular risk

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nutrional and physical activity program

Nutritional prevention and physical activity workshops associated with a substitution of saturated and/or trans fatty acids by cis-unsaturated acids via the consumption of Primevère margarine to influence lifestyle habits, quality of life and improvement of the lipid profile of women with cardiovascular risk

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI \> 25kg/m² and/or with a waist circumference \> 88 cm
* Regularly consuming butter and/or "standard" margarine rich in saturated fatty acids

Exclusion Criteria

* Regularly consuming "healthy" margarine enriched with omega 3 (Primevere, St Hubert ω3 ...) or with phytosterols (Pro-active)
* Consuming omega-3 rich food supplements within 3 months of inclusion
* Treated with lipid-lowering agents (statins), antidiabetic or antihypertensive drugs for less than 3 months
* Suffering of eating disorders
* Presenting a medical contraindication to the practice of physical activity
* Having previously participated in a similar prevention program
* Suffering from serious chronic diseases (cancer, serious cardiovascular history, etc.)
Minimum Eligible Age

40 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Pasteur de Lille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jean-Michel Lecerf

Principal Invesigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Michel Lecerf, MD

Role: PRINCIPAL_INVESTIGATOR

Institut Pasteur de Lille - NutrInvest

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NutrInvest - Institut Pasteur de Lille

Lille, Nord, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Coralie BERTHIER, PhD

Role: CONTACT

0320877333 ext. 0033

Jean-Michel LECERF, MD

Role: CONTACT

0320877771 ext. 0033

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Coralie Berthier, PhD

Role: primary

0320877333 ext. 0033

Bérengère Legendre

Role: backup

0320877346 ext. 0033

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A00249-36

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Heart-health Promotion
NCT05949892 COMPLETED NA
CVD Risk Reduction Trial
NCT00473785 COMPLETED NA
Lifestyle Heart Trial
NCT00000471 COMPLETED PHASE2